“…Remarkably, in NF2 patients, the tumour burden (including meningiomas) is usually defined at a young age, with fewer tumours arising de novo later in adulthood (da Cruz et al, 2000). Moreover, the typical growth rate of benign meningiomas is slow (Olivero et al, 1995;Nakamura et al, 2003), and most meningiomas remain asymptomatic throughout life (Vernooij et al, 2007), such that nearly half of all meningiomas are incidentally discovered at autopsy (Nakasu et al, 1987). These observations suggest that meningioma initiation from a common PGDS ( þ ) progenitor cell may be an early event, whereas tumour development may take decades more to form by the addition of genetic and/or epigenetic events.…”